Studymoderate evidence
Development of a nalmefene formulation suitable for a community-use auto-injector.
British journal of clinical pharmacology·July 14, 2026·PMID 42448614
Why it mattersRapid reversal of opioid-induced respiratory depression is critical in community overdose settings where advanced life support is not immediately available. A faster-acting intramuscular nalmefene formulation could improve outcomes by reducing time to restoration of breathing.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled